Molecules/CAPLACIZUMAB

CAPLACIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2018

Mechanism of action: von Willebrand factor inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ALX-0081CabliviCAPLACIZUMABCAPLACIZUMAB YHDPCAPLACIZUMAB-YHDP

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to CAPLACIZUMAB

Loading drug network...